Tag: CC3

JC: AVP in Haemorrhagic Shock. St Emlyn’s

Blood product transfusion can be lifesaving for patients who have suffered major trauma, but the associated side-effects and risks, mean that most people would agree that less is more. This paper by Sim et al

JC: D-K-hoorAy! New Paeds DKA guidelines

On Monday, the British Society for Paediatric Endocrinology and Diabetes published interim guidelines on the management of diabetic ketoacidosis (DKA) in our younger patients (under the age of 18). NICE are planning to fully review

The VITAMINS trial

JC: The Vitamins trial. Hydrocortisone, Vit C and Thiamine (Marik protocol – or not?) in sepsis. St Emlyn's

You may remember the controversy about Paul Marik’s suggestions that a combination of Vitamin C, steroids and Thiamine (sometimes known as HAT​1​) is a cure all for sepsis. There were some rather dramatic claims that

JC: The PEPTIC study PPI vs H2RBs on the ICU. St Emlyn's

The PEPTIC study is a randomised controlled trial of a Proton Pump Inhibitor (PPI) vs. Histamine-2 Receptor Blockers for ulcer prophylaxis on the ICU. Think Omeprazole vs. Ranitidine as your choice of prophylaxis. Although there

JC: The 65 trial. Targeting MAP in sepsis. St Emlyn's at #CCR20

Editors note: This blog is based on the presentation of the 65 trial at the Critical Care Reviews conference in Belfast. We will add more data, and be able to add a more detailed critical

JC: Rocuronium or Suxamethoniun for RSI. St Emlyn's

We’re always a little cautious (scared) about entering any sort of emergency airway debate on social media as opinions are usually strongly held, and evidence is often of the lighter variety. One of the more

JC: IN Fentanyl vs Ketamine for analgesia in PED. St Emlyn’s

Last year we reviewed a pilot RCT comparing IN Fentanyl vs IN Ketamine in kids​1,2​. We concluded that they were probably similar in analgesic effect but that Ketamine had a higher adverse event rate. Here

CRASH-3

JC: Tranexamic Acid (TXA) in Head Injury. The CRASH-3 results. St Emlyn’s

St Emlyn’s had sight of a pre-publication copy of the CRASH-3 trial from the trial team. This allowed us to prepare this blog in advance of publication. The trial authors have not been involved in

Thromboprophylaxis in Lower Limb Immobilisation #RCEMASC2019

Now the TiLLI project has been completed, I have been asked to give a late breaking abstract presentation at the upcoming annual scientific conference of the Royal College of Emergency Medicine (RCEM), to discuss the

Clot’s the Problem? Vena Cava filters in trauma patients. St Emlyn’s

No one likes getting a pulmonary embolism. Or a deep vein thrombosis. And because about 60% of all blood clots are associated with hospitalisation for acute illness​1​, we take the idea of prophylaxis very seriously.

Translate »